CL2012001035A1 - Oral pharmaceutical composition comprising at least one progestagen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception. - Google Patents
Oral pharmaceutical composition comprising at least one progestagen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception.Info
- Publication number
- CL2012001035A1 CL2012001035A1 CL2012001035A CL2012001035A CL2012001035A1 CL 2012001035 A1 CL2012001035 A1 CL 2012001035A1 CL 2012001035 A CL2012001035 A CL 2012001035A CL 2012001035 A CL2012001035 A CL 2012001035A CL 2012001035 A1 CL2012001035 A1 CL 2012001035A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- contraception
- antioxidants
- progestagen
- oral pharmaceutical
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica oral que comprende al menos un progestágeno y un derivado de folato, antioxidantes y un recubrimiento antihumedad; uso de la composición en la contracepción.Oral pharmaceutical composition comprising at least one progestogen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2012001035A CL2012001035A1 (en) | 2012-04-24 | 2012-04-24 | Oral pharmaceutical composition comprising at least one progestagen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2012001035A CL2012001035A1 (en) | 2012-04-24 | 2012-04-24 | Oral pharmaceutical composition comprising at least one progestagen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012001035A1 true CL2012001035A1 (en) | 2012-07-13 |
Family
ID=69590303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012001035A CL2012001035A1 (en) | 2012-04-24 | 2012-04-24 | Oral pharmaceutical composition comprising at least one progestagen and a folate derivative, antioxidants and an anti-humidity coating; use of the composition in contraception. |
Country Status (1)
Country | Link |
---|---|
CL (1) | CL2012001035A1 (en) |
-
2012
- 2012-04-24 CL CL2012001035A patent/CL2012001035A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP21072161A (en) | LINACLOTIDE DELAYED RELEASE COMPOSITIONS | |
NZ712350A (en) | Abiraterone acetate formulation | |
TR201908596T4 (en) | Spiro-lactam NMDA receptor modulators and their uses. | |
MX2015009105A (en) | Solid solution compositions and use in chronic inflammation. | |
EP2569330A4 (en) | Chlorotoxin variants, conjugates, and methods for their use | |
MX2016001424A (en) | Sweetener compositions. | |
TR201903569T4 (en) | A delayed release drug formulation. | |
CL2012003075A1 (en) | Pharmaceutical composition in pazopanib solution, stable and for ophthalmic use; method for the preparation of said solution. | |
BR112015018095A2 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MX366317B (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases. | |
CO2019008103A2 (en) | Pharmaceutical compositions for combination therapy | |
CO2017002472A2 (en) | Abiraterone acetate formulation | |
BR112018002983A2 (en) | composition comprising a lactam and an alcohol | |
NI201200157A (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING HYDROMORPHONE AND NALOXONE | |
UY34730A (en) | PHARMACEUTICAL FORMULATIONS THAT INCLUDE CCR3 ANTAGONISTS | |
AU2016289474B2 (en) | HBED-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents | |
CL2017000587A1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
CL2013000069A1 (en) | Compounds derived from fused heterocycles, s1p modulators; pharmaceutical composition; and use in neurodegenerative diseases. | |
BR112014025416A2 (en) | ANTIMALARIC AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THEM AND USE OF THE SAME. | |
BR112013023575A2 (en) | “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof” | |
NI201000212A (en) | DRONEDARONE FOR THE PREVENTION OF CARDIOVERSION. | |
IL238851A0 (en) | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof | |
CY1118277T1 (en) | STABLE PHARMACEUTICAL FORM PEXIGANANIS | |
HRP20130082A2 (en) | Pharmaceutical composition with sustained release of trimetazidine | |
CL2015000610A1 (en) | Isoxazolidine derivatives |